Skip to main content

New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial

An innovative treatment significantly increases the survival of people with malignant mesothelioma, according to results from a clinical trial led by Professor Peter Szlosarek from the Centre for Cancer Cell and Molecular Biology in Barts Cancer Institute.

Published on:
Back to top